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Introduction
According to the World Health Organization (WHO), 
cervix was the second most common cancer in the 
reproductive system of the female genitalia in 2004 
and about half of million new cases of this cancer are 
diagnosed annually in the world, so that more than half 
of them lose their life (World Health Organization., 
2002). Eighty percent of the people with this cancer are 
in developing countries (Schmoll et al., 2009). Two out 
three of these cases are identified in advanced stages of the 
disease, with a very low chance of survival (Bazaz et al., 
2017). In developing countries, the rate of cervical cancer 
and its mortality are much higher than advanced countries 
(Ferlay J., 2004). Unfortunately, there are no accurate 
statistics about the incidence of cervical cancer in Iran, 
but in different reports, the annual amount was about 6-7 
cases per 100,000 persons (De Martel et al., 2012, Siegel 
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et al., 2015). According to global reports, mortality rates 
are higher in the Asian and Pacific countries, as in 2009, 
from 551 patients with cervical cancer, 211 patients died 
in the same year in Iran (De Martel et al., 2012).
The mean age of patients with cervical cancer is 52.2 
and its age distribution is bicameral, so that its peak is 
between 35-39 years and 60-64 years (Vaisy et al., 2012). 
There were approximately 528,000 new cases of cancer 
occurred in the world in 2012. In less developed countries, 
12% of all cancers in women consisted of cervical cancer 
and nearly 9 out of 10 deaths from this cancer in the world 
are related to these countries. The least cervical cancers are 
in Australia / New Zealand and the Western Asia, but it is 
remained the most common cancer among women in the 
east and middle of Africa. The estimated deaths from this 
cancer in worldwide were 266,000 cases in 2012 (World 
Health Organization, 2013).
Various causes have been reported for cervical cancer 
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including long-term oral contraceptive use, low age at first 
intercourse, low age at first delivery, having a lot of sexual 
partners throughout life, having a lot of term pregnancy, 
high parity, smoking, illiteracy, low literacy, human 
papillomavirus, low socioeconomic status, etc. (Azadi et 
al., 2011). The vulnerable group of society against cervical 
cancer include: elderly people, people with low income 
and no insurance, but it is still controversial how they 
interact with these factors of cervical cancer and which of 
these factors have a huge impact on screening, diagnosis 
and survival of patient (Federico et al., 2010).
Determining the survival rates of patients with cancer 
is one of the ways that contribute community health 
workers to the better development of health care services, 
the implementation of cancer-related programs and the 
assessment of the impact of new therapies. Studies not 
only reveals the burden of disease in society, but also 
assesses the relationship between different factors with 
survival rates in patients (Semnani et al., 2008). In fact, 
survival Rate is the calculation of the survivability rate 
of patients from the first date of diagnosis to death time 
(Yazdanbod et al., 2005). In different Studies about 
survival rates in cervical cancer, some factors have been 
reported as important factors associated with survival 
such as the high age of diagnosis, repeated infections with 
the human papillomavirus virus and histology of tumor 
(Federico et al., 2010; Hosseini et al., 2012; Roshany et 
al., 2012; Serur et al., 1995).  
So far, no study has been done with the aim of 
explaining the appropriate model for survival analysis in 
patients with cervical cancer in West Azerbaijan. Therefore, 
in this research, after fitting any of the regression models 
to the observations and comparing them, a suitable and 
effective regression model for data about survival time 
of patients with cervical cancer referred to Motahhari 
Hospital of Urmia city was performed and the role of 
determinants was identified.
Materials and Methods 
In this historical retrospective study, all patients with 
cervical cancer who referred to Motahhari Hospital of 
Urmia during 2004 and 2015 were included in the study 
and consisted of 109 women with cervical cancer and 
have been followed up. The data were collected using 
checklist which filled with records of patients. It should be 
mentioned that the only referral center for cervical cancer 
in West Azerbaijan is Shahid Motahhari Educational 
Center in Urmia city. 
People who were not native in West Azerbaijan 
province, were excluded from this study. The survival 
time variable in this study was from diagnosis to death. 
Therefore, people who were alive until the end of the 
study or were death for non-cancer reason or excluded 
for any reason, considered as censored observations. 
Survival of patients were analyzed using the best fitted 
statistical model with the studied factors (age, history 
of surgery, history of pap smear, time of last treatment, 
stage of diagnosis, number of wife, recurrence of disease, 
tumor grade, smoking, tumor type, tumor size, cervical 
cancer, number of marriages, history of radiotherapy, time 
of first treatment).
Statistical Analysis
The survival function of patients was estimated using 
Kaplan-Meier method. To determine the risk factors, 
Log-Rank test was used to investigate the effect of each 
of the variables and the adjusted effects of the important 
factors in univariate analysis of patients’ survival with Cox 
proportional regression model using Forward Stepwise 
Likelihood Ratio Method with PE = 0.1, PR = 0.15 were 
determined. Data were analyzed using SPSS / Win 22 
software. There was no intervention in this study and the 
required data were extracted from the patients’ records 
using a checklist without mentioning the name. In all 
stages of the research, the secrets of patients remained 
confidential and the results of the study were reported 
in group.
Results
Of the 109 patients, the mean (SD) time of diagnosis 
was 50.1% (11.7) years. The mean (SD) and median of 
follow-up time was 38.23 (32.50) and 27.1 months (Mim:2 
Figure 1.Survival Function of Patinas with Cervical Cancer 
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months and Max:132 months). Ninty-Three of patients 
(88.7%) were in urban area. The mean (standard deviation) 
and median age of the marriage were 18.9 (4.00) and 18 
years of old which 70 patients (64.2%) were married at 
the age of less than 20 years.
Ninety-five women patients (87.2%) were married 
once and 14 patients (12.8%) at least twice. Also, among 
their husbands, 87 persons (79.8%) were married once 
and 22 persons (20.2%) at least twice. The mean (SD), 
median, minimum and maximum age of menarche were 
14.27 (1.5), 14, 11 and 18 years, respectively. Only 4 
patients (7.3%) were smoker, 71 patients (65.1%) were 
non-smoker and 34 (31.2%) were unknown because there 
was no any information in their records. 
In terms of the type of cancer histology, 99 patients 
(90.8%) were Squamous cell carcinomas (SCC) and 
10 patients (9.2%) were adenocarcinoma. In terms of 
the recurrence, 33 patients (30.3%) were reported with 
recurrence, and 76 patients (69.7%) without recurrence. 
Totally, 92 patients (84.4%) were undergone radiotherapy 
and 17 patients (15.6%) did not receive radiotherapy.
According to FIGO tumor classification, 43 patients 
(39.4%) had grade I, 47 patients (43.1%) had Grade II and 
19 patients (17.4%) had Grade III and higher. During the 
study, 30 patients (27.5%) died and 79 patients (73.5%) 
were considered as censoring observations from the right. 
Summary of results is presented in Table 1.
Estimates of survival rate of six months and one, three, 
five and seven years were 99%, 96.9%, 85.2%, 73.1% 
and 57.7%, respectively. The mean (SD) survival time of 
patients with 95% confidence intervals were 86.31 (6.46) 
and (98.9, 73.6) months, respectively (Figure 1).
In univariable analysis, the risk factors for survival 
time in cervical cancer patients were evaluated using 
log-rank test. Meanwhile, the mean survival time of 
patients with recurrence was 38.8 months and significantly 
reduced compared to non-recurrence patients with 102.5 
months (P <0.001). The mean survival time of patients 
aged less than 20 years was 73.8 months, which was 
significantly different with patients aged twenty and over 
with 117.3 months (P = 0.017). 
Variable Frequency Percent
Place of residence
     Urban 93 85.3
     Rural 16 14.7
Age at diagnosis
     <50 49 45
     >=50 60 55
Age of marriage
     >=20 39 35.8
     <20 70 64.2
Time of marriage
     1 95 87.2
     ≤2 14 12.8
Histology Type
     SCC* 99 90.8
     Adenocarcinoma 10 9.2
Recurrence of the disease
     No 76 69.7
     Yes 33 30.3
Radiotherapy
     No 92 84.4
     Yes 17 15.6
FIGO Stage
     I 43 39.4
     II 47 43.1
     III+VI 19 17.4
Follow up For all patients (month) 
     Total N( N of Events) 109 (30)
     Mean (SD) 37.3 ±32.0
     Median 27.1
     Min-Max 2-132
Table 1. Demographic Data of Patients with Cervical 
Cancer
*, Squamous cell carcinoma
Figure 2. Hazard Function by Age
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The diagnosis age less than 50 years with mean 
survival time of 102.4 months was significantly different 
with 50 years and over (66.7 months) (P = 0.019). Also, 
the mean survival time of patients with gradeI: 88.1 
months, grade II: 94.7 months and grade III, and over: 41.2 
months, had statistically significant difference (P = 0.013). 
Variable Total N N of Events Means (S.D) of Survival Time Log Rank Test Sig.
Place of residence Urban 93 26 77.5 (6.9)
Rural 16 4 59.6 (6.6) 0.68
Time of marriage 1 95 25 86.9 (7.1 ) 0.8
2+ 14 5 73.3 ( 12.3)
Type of cancer SCC* 99 28 85.5 (6.9 )
Adenocarcinoma 10 2 75.3 (13.7 ) 0.54
Recurrence of the disease No 76 10 102.5 (5.9 ) <0.001
Yes 33 20 38.8 (7.8 )
Radiotherapy Yes 92 23 89.8 (7.1 ) 0.35
No 17 7 53.7 ( 7.7)
Age <50 49 9 102.4 ( 8.5) 0.019
>=50 60 21 66.7 ( 7.9)
Age of marriage >=20 39 3 117.3 (8.1 )
<20 70 27 73.8 (6.8 ) 0.017
Stage I 43 10 88.1 (9.1 )
II 47 11 94.7 (9.3 ) 0.013
III and VI 19 9 41.2 ( 6.5)
Table 2. Means of Survival Time by Risk Factor Variables (Log-Rank Test)
*, Squamous cell carcinoma
variable B SE Sig. Adjusted HR 90.0% CI 
Age <50 Reference - - - -
>=50 0.632 0.406 0.093 1.978 (1.014,3.858)
Age of marriage >=20 Reference - - - -
<20 1.16 0.615 0.059 3.189 (1.161,8.763)
Stage I Reference - - - -
II 0.004 0.438 0.992 1.004 (0.489,2.064)
III and VI 1.035 0.461 0.036 2.814 (1.318,6.010)
Recurrence of the disease No Reference - - - -
Yes 1.89 0.401 <0.001 6.618 (3.423,12.795)
Table 3. Factors Affecting Survival of Cervical Cancer (Multivariate Analysis)
Figure 3. Hazard Function by Age in Marriage 
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The place of the reeisdence, having 2 times or more 
marriage, the type of cancer and radiotherapy treatment 
did not affect the survival of patients with cervical cancer 
(P> 0.05) (Table 2).
The adjusted effect of each significant risk factor 
derived from univariable analysis were evaluated using 
the Cox proportional hazards regression model by forward 
stepwise of likelihood ratio (LR) with PE = 0.1 and PR 
= 0.15. The results of the COX model showed that the 
adjusted relative risk of patients with a diagnostic age 
of 50 years or more compared to those aged less than 50 
years was 1.978. 
The risk for married women aged less than 20 
was 3.189 compared to aged 20 years or more. The 
adjusted relative risk of dead patients with grade II was 
approximately equal to grade I (1.004) and this risk was 
higher in patients with grade III and more compared to 
grade I (2.814). The adjusted relative risk of death in 
patients with recurrence was 6.186 times higher than those 
without recurrence (Table 3) (Figures 2-5).
Discussion
Cervical cancer is the fourth most common cancer 
among women in the world (World Health Organization, 
2005). Some factors have been reported as important 
factors associated with survival in cervical cancer such 
as the high age of diagnosis, repeated infections with 
the human papillomavirus virus and histology of tumor 
(Federico et al., 2010; Hosseini et al., 2012; Roshany 
et al., 2012; Serur et al., 1995). In the present study, of 
the 109 patients, the mean (SD) time of diagnosis was 
obtained 50.1% (11.7) years. The mean (SD) and median 
of follow-up time was 38.23 (32.50) and 27.1 months 
(Mim:2 months and Max:132 months). The mean score 
of survival in patients with recurrence of 38.8 months was 
significantly lower than those without recurrence (102.5) 
(P <0.001). The adjusted relative risk of mortality with 
a diagnostic age of 50 years or more compared to those 
under 50 years of age was 1.978. The risk for married 
women under age 20 was 3.189 compared to the marriage 
age of 20 years or more.
Figure 4. Hazard Function by Stage Type
Figure 5. Hazard Functio by Odbimarye
Hamid Reza Khalkhali et al
Asian Pacific Journal of Cancer Prevention, Vol 201350
In the present study with diagnosis age less than 
50 years with mean survival time of 102.4 months was 
significantly different with 50 years and over (66.7 
months), Serur et al., (1995) had a study on age, substance 
abuse, and survival of patients with cervical cancer 
performed on 1,173 patient records that had been recorded 
during 1967-1988. The results of this study showed that 
women over 70 years had a lower chance of survival 
compared to younger women at stage III. Drug abuse was 
common among younger patients, and patients who had 
smoking, substance abuse and alcohol, had lower survival 
rates, which was consistent with the present study.
In a study conducted by Christopher Federico et al., 
(2010) in Netherlands about the relationship among age, 
race, medical budget and cancer of the uterus in 2010 on 
125 patients with cervical cancer, concluded that there was 
no relationship between race, medical education and the 
pattern of cancer screening and survival rate, but the age 
of diagnosis 65 or over that had a low chance of survival, 
so that the age factor was significantly associated with 
a reduction in survival probability, and were consistent 
with the present study. It should be noted that education 
is effective for promotion of cancer prevention behavior 
(Zareipour et al., 2018).
In the present study in terms of the type of cancer, 99 
patients (90.8%) were in the SCC group and 10 patients 
(9.2%) were in the adenocarcinoma group. In the study 
of S Bulk et al., (2003) the survival rate of women with 
cervical cancer were evaluated, the results showed that 
SCC incidence have decreased while the incidence of 
adenocarcinoma was unchangeable. Indeed, patients with 
adenocarcinoma had lower survival rate compared to SCC 
that was related to histology of tumor, these results were 
inconsistent with the present study because there was no 
relationship between the type of cancer and survival rate 
in the present study. 
In the study conducted by Razak et al., (2013) 
five-year survival among patients with cervical cancer 
treated in Malaysia were evaluated on 120 cervical 
cancer patients diagnosed during 1995-2007. The survival 
probability was determined using the Kaplan-Meier 
method and the log-rank test was applied to compare 
the survival distribution between groups. The overall 
five-year survival was 39.7% with a median survival time 
of 40.8 months. The log-rank test showed that there were 
survival differences between the groups for the: stage at 
diagnosis, which these results were consistent with the 
present study, so that the risk for married women aged less 
than 20 was 3.189 compared to aged 20 years or more. 
The adjusted relative risk of dead patients with grade II 
was approximately equal to grade I (1.004) and this risk 
was higher in patients with grade III and more compared 
to grade I (2.814).
As well as, in the study of Muhamad et al., (2015) 
they reported that data were collected during 2000-2005 
and Kaplan Meier analyses were conducted to identify 
the overall survival rates and median survival time of 
patients with cervical cancer. A total of 5,859 patients were 
included. The median survival time for cervical cancer in 
this study was 65.8 months and the 5-year survival rate 
was 71.1%. The overall observed survival rates at 1, 3 
and 5 years were 94.1%, 79.3% and 71.1% respectively. 
These results were consistent with the results of the present 
study so that estimates of survival rate of six months and 
one, three, five and seven years were 99%, 96.9%, 85.2%, 
73.1% and 57.7%, respectively. 
The present study was done on stage I, II and III and 
the adjusted relative risk of dead patients with grade II 
was approximately equal to grade I (1.004) and this risk 
was higher in patients with grade III and more compared 
to grade I (2.814). Lai et al., (2013) performed a study to 
assess the benefits of the 2009 International Federation 
of Gynecology and Obstetrics (FIGO) staging system for 
survival of patients with Stage IIA1 and IIA2 cervical 
cancer. A study cohort of 51 patients with Stage IIA 1 
and 2 was retrospectively collected from the 2004-2009 
hospital-based. The survivorship and overall survival 
were compared between these two groups (Stages IIA1 
and IIA2) using log-rank test. Thirty-six and 15 patients 
were classified into Stages IIA1 and IIA2, respectively. 
Stage IIA2 patients were younger than those with Stage 
IIA1 disease but no significant difference was observed in 
confirmed pelvic lymph node status. Although the 2-year 
and 5-year overall survival was better among Stage IIA1 
patients, there was no significant difference in survival 
between Stage IIA1 and IIA2 groups (2-year, 90.6% vs. 
77.8%; 5-year, 86.3% vs. 51.9%, p = 0.218).
These results in terms of survival rate between stages 
were approximately close to the results of the present study 
because there was no significantly difference between 
stage I and II.
Those who died before the end of the study or did 
not recover and excluded in any way during study raised 
the censored patients of the study, which was a kind of 
selection bias and can affect the validity of survival time 
among patients.
According to results, the mean survival time of patients 
with age more than 20 years was approximately 2 times 
(117.3 months) higher than patients with age less than 20 
years (73.8 months). The low age of marriage increases 
the occurrence of advanced stages of cancer in older ages 
and as a social and cultural factor has a significant effect 
on the survival of patients with cervical cancer. Therefore, 
it should be considered important to improve the general 
awareness of people and coverage of health services in 
prevention and survival of patients with cervical cancer.
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